Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03394131
Other study ID # Hydrodissection of CT in RA
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 1, 2017
Est. completion date August 1, 2018

Study information

Verified date July 2018
Source Assiut University
Contact Manal Hassanien, MD
Phone 01062679200
Email manal_hassanien@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Carpal tunnel syndrome (CTS) is a common peripheral entrapment neuropathy in Rheumatoid arthritis patients proved by nerve conduction studies and ultrasound parameters, this study aims to evaluate the effect of hydro-dissection using insulin versus hyalase versus saline, ultrasounic guided as an effective treatment


Description:

Carpal tunnel syndrome (CTS) is a common peripheral entrapment neuropathy in Rheumatoid arthritis patients proved by nerve conduction studies and ultrasound parameters, this study aims to evaluate the effect of hydro-dissection of median nerve inside CT twice injections with interval 2 weeks using insulin and 10 cc saline versus hyalase and 10 cc saline versus 10 cc saline, ultrasounic guided as an effective treatment of CT


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date August 1, 2018
Est. primary completion date May 1, 2018
Accepts healthy volunteers No
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria:

- Rheumatoid arthritis in remission

Exclusion Criteria:

- active Rheumatoid arthritis

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Hylase
hydro-dissection injection of median nerve inside carpal tunnel using hyalase and 10 cc saline
Insulin
hydro-dissection injection of median nerve inside carpal tunnel using 10 IU insulin and 10 cc saline
Other:
saline
hydro-dissection injection of median nerve inside carpal tunnel using 10 cc saline

Locations

Country Name City State
Egypt Manal Hassanien Assiut Assuit

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary pain intensity Visual analog scale 0-100 6 months
Secondary nerve conduction sensory velocity 6 months
Secondary ultrasound cross sectional area 6 months